Health systems across the U.S. are investing heavily in enterprise technologies, yet many struggle to measure the full scope of benefits, according to a recent Deloitte report. While 80% of executives say evaluating technology value is essential, most still rely primarily on traditional

Become a Member

Members have access to all articles.

Membership
measures such as implementation costs and direct savings. A survey of 25 senior technology and finance leaders found that fewer than half routinely assess impacts on patient experience, clinician productivity, or brand reputation, factors that carry significant long-term value. 

Recognizing this, many organizations now define value more broadly, citing benefits such as enhanced clinical quality, improved staff efficiency, and better patient care. “We look at the potential for more efficient operations through consolidating functions, but equally at the improvements to employee and patient experience,” one regional health-system executive explained.

To bridge this “tech value gap,” the report outlines three strategic steps. First, institutions should adopt a comprehensive value taxonomy that blends financial, clinical, workforce, and reputational metrics. Second, they must embed accountability through value-governance structures that assign clear ownership and monitor performance over time. Third, health systems should invest in data and analytics infrastructure, ensuring data quality, interoperability, and ongoing measurement to better capture both tangible and intangible returns. By applying these practices, organizations may convert technology investments into sustainable value for patients, staff, and stakeholders.

Read more